BLISS GVS PHARMA
Back to Balance Sheet
|
BLISS GVS PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹37 Cr | ₹51 Cr | ₹43 Cr | ₹29 Cr | ₹45 Cr |
What is the latest Total Non-Current Liabilities ratio of BLISS GVS PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹37 Cr |
| Mar2024 | ₹51 Cr |
| Mar2023 | ₹43 Cr |
| Mar2022 | ₹29 Cr |
| Mar2021 | ₹45 Cr |
How is Total Non-Current Liabilities of BLISS GVS PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹37 Cr | -27.20 | |
| Mar2024 | ₹51 Cr | 19.52 | |
| Mar2023 | ₹43 Cr | 46.71 | |
| Mar2022 | ₹29 Cr | -35.46 | |
| Mar2021 | ₹45 Cr | - | |
Compare Total Non-Current Liabilities of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹1,751.4 Cr | 3.7% | 9% | 26% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,160.0 Cr | 1.7% | 7.3% | 0% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,288.0 Cr | 1.8% | 0.9% | 6.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹126,440.0 Cr | 1.3% | 4.4% | 14.9% | Stock Analytics | |
| CIPLA | ₹123,149.0 Cr | 0.9% | -2.9% | 1.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,369.0 Cr | 0.5% | -3.1% | 3.3% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 3.7% |
9% |
26% |
| SENSEX | 0.1% |
1.1% |
8.4% |
You may also like the below Video Courses